*

Market Insights

Stock screens updated daily — built in Wright’s visual language.

Stock screens updated daily — built in Wright’s visual language.

Top Growth Stocks

Growth stocks are equities of companies expected to experience rapid revenue and earnings growth, outperforming the overall market. Key characteristics include high potential for capital appreciation, typically trading at premium valuations due to their growth prospects. Advantages of growth stocks include the potential for significant returns over time, especially in a bullish market environment. In the current market, growth stocks are particularly relevant as investors seek opportunities in sectors with robust growth potential, such as technology and healthcare.

Updated:
Ticker Security Name ⇅ PrevClose Beta MarketCap PE Ratio ⇅ Dividend Yield PBV Ratio ⇅ Category
ANANTRAJ Anant Raj Ltd. 533.05 1.016 16771.467 41.322 0.002 4.211 Mid-Cap
CGCL Capri Global Capital Ltd. 177.24 0.306 13125.966 33.256 0.001 3.143 Mid-Cap
ASTRAZEN Astrazeneca Pharma India Ltd. 8919.0 0.434 19188.844 191.205 0.003 27.144 Mid-Cap
CHOICEIN Choice International Ltd. 753.85 0.376 9596.442 62.893 0.0 10.351 Mid-Cap
KRN KRN Heat Exchanger And Refrigeration Ltd. 715.2 0.0 5774.35 141.443 0.0 11.091 Mid-Cap
CCL CCL Products (India) Ltd. 994.0 0.609 7616.44 26.774 0.008 4.033 Mid-Cap
ASTRAMICRO Astra Microwave Products Ltd. 903.95 1.073 5916.031 42.517 0.003 5.797 Mid-Cap
AURIONPRO Aurionpro Solutions Ltd. 932.35 0.775 7208.391 38.373 0.001 4.928 Mid-Cap
CENTURYPLY Century Plyboards (India) Ltd. 765.6 0.969 15684.282 71.174 0.001 6.679 Mid-Cap
CAPLIPOINT Caplin Point Laboratories Ltd. 1731.2 0.752 14000.958 26.302 0.003 5.291 Mid-Cap
No data found for this filter.

Select a filter to view information.

Details

About Anant Raj Ltd. and Its Industry:

Anant Raj Ltd. is a real estate development company based in India that engages in the construction and development of residential, commercial, and retail properties. With a focus on creating innovative and sustainable real estate projects, Anant Raj Ltd. has established itself as a prominent player in the real estate industry, delivering quality properties that cater to the evolving needs of customers. The company's projects often feature modern amenities, thoughtful design elements, and a commitment to environmental sustainability, setting it apart in the competitive real estate landscape. In the face of increasing competition and regulatory challenges in the real estate sector, Anant Raj Ltd. faces the need to continuously innovate and differentiate its offerings to maintain its market position.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹533.05
    • Market Cap: ₹16771.467
    • Category: Mid-Cap
    • Beta: 1.016
  • P/E Ratio: 41.322
  • Dividend Yield: 0.002%
  • Price-to-Book Value (PBV): 4.211

About Capri Global Capital Ltd. and Its Industry:

Capri Global Capital Ltd. is a financial services company that specializes in providing a wide range of financial products and services. The company operates in various segments, including retail finance, housing finance, and wealth management. Capri Global Capital plays a significant role in the industry by offering customized financial solutions to individuals and businesses, thus contributing to the overall growth and development of its clients. As with any company in the financial sector, Capri Global Capital faces challenges in navigating through regulatory changes, managing risks associated with lending practices, and staying competitive in a dynamic market environment. However, the company also has opportunities to expand its market reach, enhance its technological capabilities for better service delivery, and diversify its product offerings to meet the evolving needs of its customers.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹177.24
    • Market Cap: ₹13125.966
    • Category: Mid-Cap
    • Beta: 0.306
  • P/E Ratio: 33.256
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 3.143

About Astrazeneca Pharma India Ltd. and Its Industry:

AstraZeneca Pharma India Ltd. is a renowned pharmaceutical company operating in the Indian market. The company focuses on research, development, manufacturing, and marketing of pharmaceutical products across various therapeutic areas such as cardiovascular, respiratory, oncology, and diabetes. AstraZeneca Pharma India Ltd. plays a significant role in providing innovative healthcare solutions to address the diverse medical needs of the Indian population. Challenges for AstraZeneca Pharma India Ltd. include navigating the complex regulatory environment in the pharmaceutical industry, managing pricing pressures, and staying competitive in a rapidly evolving market.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹8919.0
    • Market Cap: ₹19188.844
    • Category: Mid-Cap
    • Beta: 0.434
  • P/E Ratio: 191.205
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 27.144

About Choice International Ltd. and Its Industry:

Choice International Ltd. is a leading financial services company that provides a wide range of investment products and services to clients globally. With a strong reputation for innovation and customer service excellence, the company has established itself as a key player in the financial industry. Choice International Ltd. offers services such as investment advisory, asset management, wealth planning, and brokerage services, catering to both individual and institutional clients. In the highly competitive financial services industry, Choice International Ltd. faces challenges such as regulatory compliance, market volatility, and technological disruptions that require constant adaptation and strategic planning. However, these challenges also present opportunities for the company to differentiate itself through enhanced customer experiences, innovative product offerings, and strategic partnerships. By addressing these challenges effectively, Choice International Ltd.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹753.85
    • Market Cap: ₹9596.442
    • Category: Mid-Cap
    • Beta: 0.376
  • P/E Ratio: 62.893
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 10.351

About KRN Heat Exchanger And Refrigeration Ltd. and Its Industry:

KRN Heat Exchanger And Refrigeration Ltd. is a prominent player in the industrial equipment sector, specializing in the design, manufacture, and maintenance of heat exchangers and refrigeration systems. With a strong focus on innovation and quality, the company caters to various industries such as oil and gas, petrochemicals, and food processing. KRN's cutting-edge technologies and seasoned expertise have solidified its position as a trusted provider of critical cooling solutions in the market. However, like many companies in the industrial equipment sector, KRN faces challenges in terms of increasing competition from both domestic and international players. Pressure to continuously enhance products and services while maintaining cost efficiency poses a significant obstacle.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹715.2
    • Market Cap: ₹5774.35
    • Category: Mid-Cap
    • Beta: 0.0
  • P/E Ratio: 141.443
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 11.091

About CCL Products (India) Ltd. and Its Industry:

CCL Products (India) Ltd. is a prominent player in the coffee industry, known for its expertise in manufacturing and exporting instant coffee. The company has a strong foothold in both domestic and international markets, catering to a diverse range of clients and consumers. Leveraging advanced technology and sustainable practices, CCL Products has built a reputation for delivering high-quality coffee products renowned for their distinct flavors and consistent quality. However, CCL Products faces challenges such as intense competition in the coffee industry, requiring continuous innovation and market differentiation to maintain its position. Additionally, fluctuations in coffee prices and exchange rates pose risks to the company's profitability.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹994.0
    • Market Cap: ₹7616.44
    • Category: Mid-Cap
    • Beta: 0.609
  • P/E Ratio: 26.774
  • Dividend Yield: 0.008%
  • Price-to-Book Value (PBV): 4.033

About Astra Microwave Products Ltd. and Its Industry:

Astra Microwave Products Ltd. is a leading provider of high-performance RF and microwave communication systems and solutions. The company specializes in designing and manufacturing a wide range of products such as microwave components, satellite communication systems, radar systems, and electronic warfare systems. With a strong focus on innovation and technological advancement, Astra Microwave has established itself as a key player in the defense and aerospace industry, catering to both domestic and international markets. Challenges facing Astra Microwave Products Ltd. include intense competition in the defense and aerospace sector, requiring continuous innovation to stay ahead of competitors. Additionally, fluctuations in government defense budgets and regulatory changes can impact the company's revenue and growth prospects.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹903.95
    • Market Cap: ₹5916.031
    • Category: Mid-Cap
    • Beta: 1.073
  • P/E Ratio: 42.517
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.797

About Aurionpro Solutions Ltd. and Its Industry:

Aurionpro Solutions Ltd. is an IT solutions provider that specializes in helping businesses across various industries embrace digital transformation. With a focus on delivering innovative technology solutions, Aurionpro offers services such as enterprise security, banking solutions, digital marketing, and customer experience management. The company's offerings cater to a wide range of clients, from financial institutions to government organizations, helping them leverage technology to enhance operational efficiency and customer experiences. Challenges faced by Aurionpro Solutions Ltd. include navigating the rapidly evolving technology landscape, staying ahead in the competitive IT solutions market, and adapting to changing client needs and preferences.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹932.35
    • Market Cap: ₹7208.391
    • Category: Mid-Cap
    • Beta: 0.775
  • P/E Ratio: 38.373
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 4.928

About Century Plyboards (India) Ltd. and Its Industry:

Century Plyboards (India) Ltd. is a leading manufacturer of plywood, laminate, and decorative veneers in India. With a strong presence in the construction and interior design industry, the company is known for its high-quality and innovative products. Century Plyboards has established itself as a trusted brand, offering a wide range of solutions for residential, commercial, and industrial applications. Its products are widely used in furniture, flooring, paneling, and other interior construction projects, making it a key player in the country's growing infrastructure sector. Despite its strong market position, Century Plyboards faces challenges such as increasing competition from both domestic and international players in the industry. This intensifying competition puts pressure on the company to constantly innovate and maintain its market share.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹765.6
    • Market Cap: ₹15684.282
    • Category: Mid-Cap
    • Beta: 0.969
  • P/E Ratio: 71.174
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 6.679

About Caplin Point Laboratories Ltd. and Its Industry:

Caplin Point Laboratories Ltd. is a pharmaceutical company based in India that specializes in the development, manufacture, and marketing of generic pharmaceutical formulations. With a focus on providing affordable healthcare solutions, Caplin Point has a diverse product portfolio encompassing a wide range of therapeutic categories. The company has a strong presence in both domestic and international markets, catering to the needs of a global customer base. Challenges and opportunities lie ahead for Caplin Point Laboratories within the pharmaceutical industry. One major challenge the company may face is the increasing competition in the generic drug market, necessitating continuous innovation and cost-efficiency to stay competitive.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1731.2
    • Market Cap: ₹14000.958
    • Category: Mid-Cap
    • Beta: 0.752
  • P/E Ratio: 26.302
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.291